z-logo
open-access-imgOpen Access
Decreased testosterone secretion index and free testosterone level with multiple symptoms for late-onset hypogonadism identification: a nationwide multicenter study with 5980 aging males in China
Author(s) -
Honggang Li,
Yiqun Gu,
XueJun Shang,
Yuanzhong Zhou,
Huiping Zhang,
Liandong Zuo,
Guangan Mei,
Wei Xia,
Huang-Tao Guan,
Wenpei Xiang,
Shan-Jie Zhou,
Chang-Chun Wan,
Baojin Hao,
Xubo Shen,
Lin-guo Tang,
Weixiong Wu,
Ying Qi,
Na Yu,
Xiangbin Kong,
Y. Chen,
Yihong Yang,
Xingrong Qing,
Chengliang Xiong
Publication year - 2020
Publication title -
aging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 90
ISSN - 1945-4589
DOI - 10.18632/aging.202227
Subject(s) - testosterone (patch) , medicine , endocrinology , index (typography) , free testosterone , androgen , sex hormone binding globulin , hormone , world wide web , computer science
Late-onset hypogonadism (LOH) is a syndrome in middle-aged and elderly men caused by age-related testosterone deficiency. Age-related change of total testosterone (TT) of Asian males is different from Caucasian population, suggesting difference for LOH identification in Asians. A nationwide cross-sectional study involving six centers in China was conducted. Totally 6296 men aged 40-79 were recruited. After exclusions 5980 men were left for analyses. The serum TT level, was neither decreased with aging nor correlated with most hypogonadal symptoms. Instead, ten hypogonadal symptoms were found to be significantly correlated with free testosterone and testosterone secretion index, thus were chosen to form a concise scale. Further analysis identified a level of free testosterone <210 pmol/L, testosterone secretion index <1.8, and the concise scale score ≧17 could be diagnosed as having significantly aggravated LOH. This study developed an evidence-based criteria for LOH identification in Chinese population and may be adopted in other Asians. It includes the impaired testosterone secretion ability and deficiency of bioavailable testosterone, which should be the main cause in LOH pathogenesis despite normal TT levels, as well as correlated multiple hypogonadal symptoms. Our results may guide the LOH treatment to increase testicular function of testosterone secretion and bioavailable testosterone.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom